| Chippewa Valley Hospital | |
| 1220 3rd Ave W, Durand, Wisconsin 54736 | |
| (715) 672-4211 | |
| Not Available |
| Name | Chippewa Valley Hospital |
|---|---|
| Type | Critical Access Hospital |
| Location | 1220 3rd Ave W, Durand, Wisconsin |
| Ownership | Voluntary non-profit - Church |
| Emergency Services | Yes |
| Medicare ID (CCN) | 521307 |
| NPI Number | 1194737817 |
| Organization Name | CHIPPEWA VALLEY HOSPITAL & OAKVIEW CARE CENTER, INC. |
| Doing Business As | CHIPPEWA VALLEY HOSPITAL |
| Address | 1220 3rd Ave W, Durand, WI 54736 |
| Hospital Type | General Acute Care Hospital - Critical Access |
| Phone Number | 715-672-4211 |
News Archive
Takeda Pharmaceutical Company Limited announced today that Takeda Global Research & Development Center, Inc. U.S., submitted a New Drug Application to the U.S. Food and Drug Administration for an investigational fixed-dose combination of azilsartan medoxomil plus chlorthalidone for the treatment of hypertension, or high blood pressure.
Physician-scientists at Oregon Health & Science University Doernbecher Children's Hospital are challenging the way pediatric neurologists think about brain injury in the pre-term infant. In a study published online in the Jan. 16 issue of Science Translational Medicine, the OHSU Doernbecher researchers report for the first time that low blood and oxygen flow to the developing brain does not, as previously thought, cause an irreversible loss of brain cells, but rather disrupts the cells' ability to fully mature.
Mirada Medical, a global leader in Artificial Intelligence software for the treatment of cancer, has announced today further global installations of DLCExpert, the world's first commercially available AI-powered auto contouring software for cancer treatment planning and the only system with over one year of clinically proven use.
Researchers from the University of California San Diego School of Medicine have found a way to create new neurons in a mouse model of Parkinson's disease. The severely debilitating and progressive neurodegenerative disease, as of now, has no cure, and this breakthrough could help hundreds of thousands of patients with the condition feel experts.
› Verified 4 days ago
| NPI Number | 1285747519 |
| Organization Name | CHIPPEWA VALLEY HOSPITAL & OAKVIEW CARE CENTER, INC. |
| Doing Business As | ADVENTHEALTH DURAND |
| Address | 1220 3rd Ave W, Durand, WI 54736 |
| Hospital Type | General Acute Care Hospital - Critical Access |
| Phone Number | 715-672-4211 |
News Archive
Takeda Pharmaceutical Company Limited announced today that Takeda Global Research & Development Center, Inc. U.S., submitted a New Drug Application to the U.S. Food and Drug Administration for an investigational fixed-dose combination of azilsartan medoxomil plus chlorthalidone for the treatment of hypertension, or high blood pressure.
Physician-scientists at Oregon Health & Science University Doernbecher Children's Hospital are challenging the way pediatric neurologists think about brain injury in the pre-term infant. In a study published online in the Jan. 16 issue of Science Translational Medicine, the OHSU Doernbecher researchers report for the first time that low blood and oxygen flow to the developing brain does not, as previously thought, cause an irreversible loss of brain cells, but rather disrupts the cells' ability to fully mature.
Mirada Medical, a global leader in Artificial Intelligence software for the treatment of cancer, has announced today further global installations of DLCExpert, the world's first commercially available AI-powered auto contouring software for cancer treatment planning and the only system with over one year of clinically proven use.
Researchers from the University of California San Diego School of Medicine have found a way to create new neurons in a mouse model of Parkinson's disease. The severely debilitating and progressive neurodegenerative disease, as of now, has no cure, and this breakthrough could help hundreds of thousands of patients with the condition feel experts.
› Verified 4 days ago
| Able to receive lab results electronically | Yes |
| Able to track patients' lab results, tests, and referrals electronically between visits | Yes |
News Archive
Takeda Pharmaceutical Company Limited announced today that Takeda Global Research & Development Center, Inc. U.S., submitted a New Drug Application to the U.S. Food and Drug Administration for an investigational fixed-dose combination of azilsartan medoxomil plus chlorthalidone for the treatment of hypertension, or high blood pressure.
Physician-scientists at Oregon Health & Science University Doernbecher Children's Hospital are challenging the way pediatric neurologists think about brain injury in the pre-term infant. In a study published online in the Jan. 16 issue of Science Translational Medicine, the OHSU Doernbecher researchers report for the first time that low blood and oxygen flow to the developing brain does not, as previously thought, cause an irreversible loss of brain cells, but rather disrupts the cells' ability to fully mature.
Mirada Medical, a global leader in Artificial Intelligence software for the treatment of cancer, has announced today further global installations of DLCExpert, the world's first commercially available AI-powered auto contouring software for cancer treatment planning and the only system with over one year of clinically proven use.
Researchers from the University of California San Diego School of Medicine have found a way to create new neurons in a mouse model of Parkinson's disease. The severely debilitating and progressive neurodegenerative disease, as of now, has no cure, and this breakthrough could help hundreds of thousands of patients with the condition feel experts.
› Verified 4 days ago
Chippewa Valley Hospital Critical Access Hospital Location: 1220 3rd Ave W, Durand, Wisconsin 54736 Phone: (715) 672-4211 |